ABT-510

ABT-510 · Abbott Laboratories

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for ABT-510, covering 2007-08-14 to 2013-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors [Phase 1]